CAS 916232-21-8

Fórmula: C28H19FN2O4

InChI: InChI=1S/C28H19FN2O4/c29-24-9-5-4-8-22(24)26-15-14-21(35-26)17-23-25(16-18-6-2-1-3-7-18)30-31(27(23)32)20-12-10-19(11-13-20)28(33)34/h1-15,17H,16H2,(H,33,34)/b23-17+

Clave InChI: IZPMWFSVTDOCDI-HAVVHWLPSA-N

SMILES: C1=CC=C(C=C1)CC\2=NN(C(=O)/C2=C/C3=CC=C(O3)C4=CC=CC=C4F)C5=CC=C(C=C5)C(=O)O

4-(3-Benzyl-4-{[5-(2-fluorophenyl)furan-2-yl]methylidene}-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid

CAS: 916232-21-8

Fórmula: C₂₈H₁₉FN₂O₄

Pureza: %

Forma y color: Solid

Peso molecular: 466.4599

Ref: IN-DA01BDHN

GS143

CAS: 916232-21-8

GS143

Fórmula: C₂₈H₁₉FN₂O₄

Pureza: ≥95%

Peso molecular: 466.46

Ref: 54-BUP09672

4-(3-Benzyl-4-{[5-(2-Fluorophenyl)Furan-2-Yl]Methylidene}-5-Oxo-4,5-Dihydro-1H-Pyrazol-1-Yl)Benzoic Acid

CAS: 916232-21-8

4-(3-Benzyl-4-{[5-(2-Fluorophenyl)Furan-2-Yl]Methylidene}-5-Oxo-4,5-Dihydro-1H-Pyrazol-1-Yl)Benzoic Acid

Fórmula: C₂₈H₁₉FN₂O₄

Pureza: 98+%

Peso molecular: 466.46

Ref: 54-PC108712

GS143

CAS: 916232-21-8

GS143 inhibits IκBα ubiquitination (IC50=5.2μM), suppresses NF-κB, and has anti-asthma properties without hindering proteasomes.

Fórmula: C₂₈H₁₉FN₂O₄

Pureza: 97.67%

Forma y color: Solid

Peso molecular: 466.46

Ref: TM-T25465

GS143

CAS: 916232-21-8

4-(3-Benzyl-4-{[5-(2-fluorophenyl)furan-2-yl]methylidene}-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid

Fórmula: C₂₈H₁₉FN₂O₄

Pureza: 98+%

Peso molecular: 466.46

Ref: IN-DG01021949

4-(3-Benzyl-4-{[5-(2-fluorophenyl)furan-2-yl]methylidene}-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid

CAS: 916232-21-8

Pureza: 98.0%

Peso molecular: 466.4679870605469

Ref: 10-F547680

4-[4-[[5-(2-Fluorophenyl)-2-furanyl]methylene]-4,5-dihydro-5-oxo-3-(phenylmethyl)-1H-pyrazol-1-yl]-benzoic acid

CAS: 916232-21-8

Versatile small molecule scaffold

Fórmula: C₂₈H₁₉FN₂O₄

Pureza: Min. 95%

Peso molecular: 466.5 g/mol

Ref: 3D-RLB23221